Shares of Koninklijke Philips N.V. (NYSE:PHG – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company.
A number of equities analysts have weighed in on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of Koninklijke Philips in a research report on Saturday, September 27th. Wall Street Zen cut shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd.
View Our Latest Stock Report on Koninklijke Philips
Hedge Funds Weigh In On Koninklijke Philips
Koninklijke Philips Stock Performance
NYSE PHG opened at $28.01 on Friday. The stock has a market capitalization of $26.97 billion, a price-to-earnings ratio of 147.39, a PEG ratio of 0.74 and a beta of 0.82. The stock has a 50-day moving average of $27.43 and a 200 day moving average of $25.18. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69. Koninklijke Philips has a twelve month low of $21.48 and a twelve month high of $32.62.
Koninklijke Philips (NYSE:PHG – Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.12. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%.The business had revenue of $5.05 billion during the quarter, compared to analysts’ expectations of $4.35 billion. Sell-side analysts anticipate that Koninklijke Philips will post 1.63 EPS for the current fiscal year.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Defense Stocks Surging as Ukraine Tensions Deepen
- What Does Downgrade Mean in Investing?
- Starbucks Stock Slumps; This Competitor Shows Strength
- Asset Allocation Strategies in Volatile Markets
- The Trade Desk: 2 Signs of a Comeback, 1 Risk Ahead
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.